Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acuminata, added, addedGardasilto, addedRotaTeqto, addressing, admitted, agonist, ahead, alter, Ambrilia, andZocorat, anticancer, Antimicrobial, approvedZolinzafor, argue, arose, arrangement, Arrigale, ASBMR, asFosamac, Atripla, Authorisation, Biopharma, bisphosphonate, blistering, bond, born, Bulletin, called, catalyze, ceased, Central, centralized, Chemotherapy, Cipla, Clark, commonly, complication, concept, condyloma, copy, country, coupled, Debevoise, demonstrated, demonstration, Denmark, destruction, diet, dipeptidyl, discovered, disoproxil, diversity, Dtogether, efavirenz, eitherGardasilorSilgard, EMEA, emtricitabine, Emtriva, evidence, excessive, federalVioxxcase, fee, fiscal, forFosamaxandFosamax, forSingulair, forVioxxlitigation, forZocor, FosamaxMDL, framework, frequency, frequently, fumarate, futureVioxxlegal, gaboxadol, gene, Gilead, home, Honorable, ibandronate, impairment, incretin, insufficient, interference, inverse, Ireland, Januviaalso, juror, Keenan, lamivudine, lipid, Live, LLP, load, loan, location, Los, MAA, marked, Martin, Mason, Microbiology, midway, Ministry, nerve, niacin, Nicaragua, Nicaraguan, nucleoside, ofGardasilin, ofJanuviain, ofProQuad, ofVioxxduring, ofZetiaandVytorinthrough, ofZolinza, opposing, otherVioxxShareholder, overturned, persistency, persistent, pharmacokinetic, Plimpton, postherpetic, propriety, protease, publicly, quantification, quantify, Quantifying, reassessment, recharacterizing, reconsideration, recurrent, regression, repeat, reversal, reverse, Rigby, RNA, RNAi, RotaTeq, SAB, senior, Sinclair, Sirna, slower, Smith, Sustiva, tablet, takingFosamaxOnce, taxable, tenofovir, testimony, TheFosamaxMDL, theFosamaxproduct, theZocorpatent, toVioxxand, tradename, tradenameStocrinin, transcribed, transcriptase, Truvada, twoVioxx, undisclosed, unfunded, unresolved, untreated, VioxxLitigation, viral, Viread, young
Removed:
absorption, administered, aggressively, AIIA, analyzing, ANDA, antagonist, automatically, award, branded, capped, compliance, continued, decline, defending, dual, ending, EPO, evaluating, experience, Healthcare, hearing, high, IMS, inhibition, lose, magnesium, MHRA, notified, ofPropeciaand, onNexium, Opposition, people, Ranbaxy, receiving, Specifically, stayed, sued, theVioxxShareholder, uncertain, unsettled, unsuccessful, version, whichever, withVioxx
Filing tables
Filing exhibits
Related press release
Merck Sharp & Dohme similar filings
Filing view
External links